Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MediReg in severe spermatogenesis disorders
NCT06869863Phase 2Recruiting
- Sponsor
- Lomonosov Moscow State University Medical Research and Educational Center
- Start
- Nov 2024
- Primary completion
- Dec 2025
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of MediReg in male infertility, sponsored by Lomonosov Moscow State University Medical Research and Educational Center. Started Nov 2024; status: recruiting.
02
Drugs
MediReg
03
Conditions
male infertility
Beyond the preview
Go deeper on NCT06869863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06869863.